GILD closed Monday's trading at $80.92, down 0.10%. Pfizer Inc. (PFE) is all set to acquire Medivation Inc. (MDVN) for $81.50 a share in cash for a total enterprise value of approximately $14 billion. The merger is expected to be …
Medivation has sent its shareholders on quite the ride this year. The cancer-drug company’s stock was down on its luck back in February, when the shares got caught up in a sweeping selloff in the biotech sector. The stock fell as low as …
U.S. stock futures traded lower in early pre-market trade. The Chicago Fed National Activity Index for July is schedule for release at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average fell 51 points to 18,489.00, while the Standard & …
(NYSE: AGN) announced the largest healthcare deal in history today (Monday). But despite the historic news, the PFE stock price was down 2.3% today. Allergan stock was down 3%. In a record-breaking $160 billion merger, the Pfizer …
In March, Bristol-Myers along with Pfizer Inc. (NYSE:PFE) announced data from a real-world data analysis ... You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. More Stock News: This Is Bigger than the iPhone!
Tara Clarke: Pfizer Inc. (NYSE:PFE) will soon feel the pressure from the wave of lawsuits being filed claiming that Pfizer’s blockbuster drug Lipitor – the world’s best-selling drug of all time – causes type-2 diabetes in women. With a market ...
Meanwhile, Dow component Pfizer Inc. (NYSE:PFE) helped boost the blue-chip index higher after ... at 17,832.03; the …
In after hours trade shares of Pfizer were up 1.4% following the announcement. Pfizer is set to announce third quarter results on Tuesday, October 28 before the market open. Get the latest Pfizer stock price here.
Two American pharmaceutical giants reported earnings this morning, both showing flagging sales – but one ended the day with a gain. Merck & Co. Inc. (NYSE: MRK) shares gained 1.05% to close at $58.58 while Pfizer Inc. (NYSE: PFE)
Diane Alter: The Pfizer stock price is up 0.5% today as the U.S. drug giant remains in advanced stages to buy Allergan Plc. (NYSE:AGN). Pfizer Inc. (NYSE:PFE) is pushing forward with the deal despite the best wishes of the U.S. …